The U.S. airline industry's newfound health is breeding something not seen in years: a flock of startups. All share an optimism that they can defy the odds in an industry that has seen 77 bankruptcies in the 20 years.
Gilead Sciences's new hepatitis C treatment, Sovaldi, had $3.48 billion in second-quarter sales, more than expected, continuing its historic drug launch.
Buyout firms are gobbling up collision-repair companies in an effort to consolidate a fragmented industry and find outsize profit in smaller deals.
Deutsche Bank Chief Financial Officer Stefan Krause is under pressure after U.S. authorities cited serious concerns about the German lender's financial data.
The world's largest mining company said it planned to continue ramping up iron-ore production despite tumbling prices and a global glut in supplies of the steelmaking ingredient.
American Apparel chose a new board, bringing the company a step closer to determining the fate of Dov Charney, the company's founder.
Delta Air Lines and the US Airways unit of American Airlines Group said Wednesday that they will extend their suspension of flights to Tel Aviv through Wednesday.
Many credit Obamacare, along with the improving economy.